Somerville, NJ, United States of America

Stephen J Shimshock




Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Somerville, NJ (US) (2000 - 2002)
  • Hillsbrough, NJ (US) (2014)
  • Hillsborough, NJ (US) (2004 - 2015)

Company Filing History:


Years Active: 2000-2015

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: **Innovative Contributions of Stephen J. Shimshock in Chemokine Research**

Introduction

Stephen J. Shimshock, an accomplished inventor based in Somerville, NJ, has made significant strides in the field of biopharmaceutical innovations. With a remarkable portfolio of 13 patents, his works primarily focus on developing compounds that serve as inhibitors for chemokine receptors, paving the way for new treatments for various diseases.

Latest Patents

Among his latest inventions are groundbreaking patents related to CXCR2 inhibitors and CXCR2 antagonists. These patents describe compounds of a specific formula, providing details on the structures and properties that qualify them as effective inhibitors of chemokine receptors. The compounds and their pharmaceutically acceptable salts and prodrugs hold potential for the prevention and treatment of chemokine-mediated diseases, showcasing the transformative impact of Shimshock's innovations in therapeutic development.

Career Highlights

Throughout his career, Stephen J. Shimshock has contributed valuable insights and advancements while working with notable companies such as Aventis Pharmaceuticals Inc. and Sanofi. His experience in these leading pharmaceutical firms has equipped him with a robust understanding of the complexities involved in drug development, further enhancing his capabilities as an inventor.

Collaborations

In his journey as an inventor, Shimshock has collaborated with esteemed colleagues, including Stephanie Hachtel and Juergen Dedio. These partnerships have fostered a collaborative environment that encourages the sharing of knowledge and expertise, ultimately leading to the innovative breakthroughs that define his work.

Conclusion

Stephen J. Shimshock's dedication to the field of chemokine receptor research has established him as a prominent figure in biopharmaceutical innovations. Through his numerous patents and collaborations, he continues to influence the development of therapies that address critical health concerns. His contributions exemplify the spirit of innovation that drives advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…